Quantitative BioSciences Inc.

Established in 2010, QBI was founded by scientists interested in applying the latest bioengineering approaches, including microfluidics, synthetic biology, and machine learning, to develop innovative sensor and assay solutions.

Our services are delivered by a dedicated team with extensive experience in biosensor and immunoassay technologies for a wide range of applications.

We have successfully delivered over the years on both client projects as well as high-risk, innovative R&D projects with funding from NIH, DOE, DARPA, IARPA, USDA, EPA, and NOAA.

Leadership Team

Natalie Cookson, PhD
CEO

Natalie received a B.A. in Physics from the University of Pennsylvania and a Ph.D. in Bioengineering from the University of California, San Diego. In 2010, Natalie co-founded QBI with Michael Ferry, applying her synthetic biology and microfluidics background to the development of biosensors. As CEO, Natalie manages QBI’s project budgets and schedules and oversees its government and commercial contracts.

Michael Ferry, PhD
CSO

Michael received a B.S. in Molecular, Cell and Developmental Biology from the University of California, Los Angeles and a Ph.D. in Bioengineering from the University of California, San Diego.  Michael co-founded QBI in 2010 with Natalie Cookson and has since served as the company’s CSO. Michael manages the scientific team and leads the development of innovative sensing and immunoassay technologies.

Nicholas Csicsery, PhD
Principal Scientist

Nick received his B.S. in Biological Systems Engineering from UC Davis and his Ph.D. in Bioengineering from UC San Diego. He is a bioengineer and synthetic biologist and has spearheaded QBI’s innovative immunoassay-based technologies, including the development of our VHH library and approaches for rapidly developing customized, target-specific VHH’s for customer projects.

Scott Cookson, PhD
COO

Scott received his B.S. in Engineering Physics from the University of Maine and his Ph.D. in Bioengineering from the University of California, San Diego. Scott serves as COO, applying his expertise and hands-on experience in synthetic biology, microfluidics, and engineering to the development and testing of sensor prototypes in the lab as well as in the field, working with our scientific team as well as external partners to demonstrate field robustness of our platforms.

William Mather, PhD
CIO

Will received his B.S. and Ph.D. in Physics from the Georgia Institute of Technology, after which he shifted his focus to the development of a quantitative understanding of biological systems as a postdoctoral researcher at the University of California, San Diego and an Assistant Professor at Virginia Tech. He serves as CIO and is an expert in computational biology and machine learning, and he spearheads the development of state-of-the-art computational tools at QBI.

Sarah Killgore, CPA
CFO

Sarah is a Certified Public Accountant with B.S. and M.S. degrees in Accounting. Licensed since 2008, she has held leadership positions in the public accounting, healthcare, government, and biotech industries. Sarah brings extensive expertise in accounting for federal awards and government contracting, and enjoys managing complex financial operations while navigating regulatory and financial challenges.

Our Commitment to You

At all stages of our partnership with you, we commit to:

  • Provide open and honest communication

  • Provide data and feedback frequently, and if needed, assist you in interpreting results

  • Answer your questions and respond to any concerns promptly

  • Adjust our workflow, if appropriate, based on the data and what we learn during the project, and in consultation with you

We value your partnership and look forward to working with you!